Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2011-05-25 Capital/Financing Update
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Section 708A Notice 2 pages 201.3KB
Capital/Financing Update Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001 regarding the issuance of fully paid ordinary shares by CBio Limited. It provides legal compliance statements related to the share issue and references the Corporations Act. The document is short (3530 characters) and primarily serves as a regulatory announcement about a capital raising event without detailed financial data or a full report. It is not an annual report, earnings release, or detailed financial report. The content fits the description of a Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes.
2011-05-25 English
Allotment of placement shares 2 pages 174.8KB
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 23 May 2011 from CBio Limited regarding the allotment of shares related to a previously announced placement that raised approximately $5.1 million. It mentions the number of shares allotted and that an Appendix 3B will follow. The content focuses on the share placement and allotment details, with no financial statements or detailed financial analysis included. The document length is 3446 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication of it being a full Annual Report, Interim Report, or Earnings Release. It is clearly an update on capital raising activity and share allotment. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2011-05-22 English
Appendix 3B 8 pages 479.0KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new ordinary shares, including the number of securities issued, issue price, purpose of the issue, and quotation application to the ASX. It includes sections on the class of securities, number of securities, terms, ranking, and escrow details. The document is a formal announcement related to a new share issue and application for quotation of additional securities on the ASX. It does not contain financial statements or management discussion but is a regulatory announcement about capital raising and securities issuance. This matches the definition of a 'Share Issue/Capital Change' filing, which covers announcements regarding new share issues and capital changes.
2011-05-22 English
Section 708A Notice 2 pages 201.2KB
Capital/Financing Update Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001 regarding the issuance of fully paid ordinary shares by CBio Limited. It provides legal compliance statements related to the share issuance without disclosure under Part 6D.2 of the Corporations Act. The document is short (3531 characters) and primarily serves as a regulatory announcement about a capital raising event. It does not contain financial statements, detailed financial analysis, or management discussion. The content fits the category of a Capital/Financing Update, as it informs about a share issuance and compliance with relevant laws. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2011-05-22 English
Appendix 3B 8 pages 478.5KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and references ASX rules related to new securities issuance and quotation. It details the class and number of securities issued or to be issued, terms of securities, issue price, purpose, dates of allotment, and quotation application. It also includes a quotation agreement and lists restricted securities, unquoted securities, and convertible notes. The content is focused on announcing and applying for quotation of additional securities rather than providing a financial report or earnings data. This matches the definition of a Share Issue/Capital Change announcement, which covers new share issues and capital structure changes. The document length is over 11,000 characters and contains detailed information about the securities issuance, not just a brief notice or a report publication announcement. Therefore, the correct classification is Share Issue/Capital Change (SHA).
2011-05-19 English
Section 708(A) Notice 2 pages 188.4KB
Share Issue/Capital Change Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001, which relates to the issuance of shares without disclosure under Part 6D.2 of the Corporations Act. It provides details about the issuance of 148,148 fully paid ordinary shares by CBio Limited on 20 May 2011. The document is a formal announcement to the ASX regarding a share issue and compliance with relevant sections of the Corporations Act. It does not contain financial statements, management discussion, or detailed report content. The document length is 3477 characters, which is relatively short and consistent with a regulatory announcement. This fits the category of a Share Issue/Capital Change announcement rather than a full report or other filing type.
2011-05-19 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.